Moravek, Inc

With over 45 years of experience, Moravek is a leading provider of high-quality carbon-14 and tritium labeled compounds to researchers worldwide and is one of the most trusted contract development and manufacturing organizations (CDMOs) offering radiosynthesis services. Moravek specializes in the custom production of GMP carbon-14 labeled active pharmaceutical ingredients (APIs) that are manufactured compliant with U.S. Food and Drug Administration (FDA) guidance ICH Q7 Section 19 and are suitable for use in early phase clinical trials. Moravek also offers non-GMP custom synthesis services and an extensive catalog of non-GLP radiolabeled, stable-labeled, and non-labeled compounds.